Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Saxagliptin> ?p ?o. }
Showing items 1 to 98 of
98
with 100 items per page.
- Saxagliptin abstract "Saxagliptin (rINN), previously identified as BMS-477118, is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate on the marketing of the drug. In June 2008, it was announced that Onglyza would be the trade name under which saxagliptin will be marketed.In February 2014, the U.S. FDA announced they were investigating possible cardiac morbidity risk,. based on data in an article in the New England Jourmal. That article concluded "DPP-4 inhibition with saxagliptin did not increase or decrease the rate of ischemic events, though the rate of hospitalization for heart failure was increased. Although saxagliptin improves glycemic control, other approaches are necessary to reduce cardiovascular risk in patients with diabetes."".
- Saxagliptin atcPrefix "A10".
- Saxagliptin atcSuffix "BH03".
- Saxagliptin casNumber "361442-04-8".
- Saxagliptin drugbank "DB06335".
- Saxagliptin fdaUniiCode "8I7IO46IVQ".
- Saxagliptin iupacName "(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)".
- Saxagliptin iupacName "acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile".
- Saxagliptin pubchem "11243969".
- Saxagliptin thumbnail Saxagliptin.svg?width=300.
- Saxagliptin wikiPageExternalLink cx_mh_rl_diabetestearsheet_5.html.
- Saxagliptin wikiPageExternalLink www.onglyza.com.
- Saxagliptin wikiPageID "7526977".
- Saxagliptin wikiPageRevisionID "605387173".
- Saxagliptin atcPrefix "A10".
- Saxagliptin atcSuffix "BH03".
- Saxagliptin c "18".
- Saxagliptin casNumber "361442".
- Saxagliptin chembl "385517".
- Saxagliptin chemspiderid "9419005".
- Saxagliptin drugbank "DB06335".
- Saxagliptin h "25".
- Saxagliptin hasPhotoCollection Saxagliptin.
- Saxagliptin inchi "1".
- Saxagliptin inchikey "QGJUIPDUBHWZPV-SGTAVMJGBR".
- Saxagliptin iupacName "-2".
- Saxagliptin iupacName "acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile".
- Saxagliptin legalUk "POM".
- Saxagliptin legalUs "Rx-only".
- Saxagliptin licenceEu "Onglyza".
- Saxagliptin licenceUs "Saxagliptin".
- Saxagliptin medlineplus "a610003".
- Saxagliptin molecularWeight "315.41".
- Saxagliptin n "3".
- Saxagliptin o "2".
- Saxagliptin pubchem "11243969".
- Saxagliptin routesOfAdministration "Oral".
- Saxagliptin smiles "O=C[C@@H]C35CC4CCCCC5".
- Saxagliptin stdinchi "1".
- Saxagliptin stdinchikey "QGJUIPDUBHWZPV-SGTAVMJGSA-N".
- Saxagliptin unii "8".
- Saxagliptin verifiedfields "changed".
- Saxagliptin verifiedrevid "459811747".
- Saxagliptin subject Category:Adamantanes.
- Saxagliptin subject Category:Alcohols.
- Saxagliptin subject Category:Amides.
- Saxagliptin subject Category:Bristol-Myers_Squibb.
- Saxagliptin subject Category:Dipeptidyl_peptidase-4_inhibitors.
- Saxagliptin subject Category:Nitriles.
- Saxagliptin subject Category:Nitrogen_heterocycles.
- Saxagliptin type Abstraction100002137.
- Saxagliptin type Agent114778436.
- Saxagliptin type Alcohol107884567.
- Saxagliptin type Alcohols.
- Saxagliptin type Amide114724264.
- Saxagliptin type Amides.
- Saxagliptin type Beverage107881800.
- Saxagliptin type CausalAgent100007347.
- Saxagliptin type Chemical114806838.
- Saxagliptin type Compound114818238.
- Saxagliptin type Drug103247620.
- Saxagliptin type DrugOfAbuse103248958.
- Saxagliptin type Fluid114939900.
- Saxagliptin type Food100021265.
- Saxagliptin type HeterocyclicCompound115025397.
- Saxagliptin type Liquid114940386.
- Saxagliptin type Material114580897.
- Saxagliptin type Matter100020827.
- Saxagliptin type Nitrile114827346.
- Saxagliptin type Nitriles.
- Saxagliptin type NitrogenHeterocycles.
- Saxagliptin type OrganicCompound114727670.
- Saxagliptin type Part113809207.
- Saxagliptin type PhysicalEntity100001930.
- Saxagliptin type Relation100031921.
- Saxagliptin type Substance100019613.
- Saxagliptin type Substance100020090.
- Saxagliptin type Drug.
- Saxagliptin type DrugProduct.
- Saxagliptin type FunctionalSubstance.
- Saxagliptin comment "Saxagliptin (rINN), previously identified as BMS-477118, is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate on the marketing of the drug. In June 2008, it was announced that Onglyza would be the trade name under which saxagliptin will be marketed.In February 2014, the U.S.".
- Saxagliptin label "Saksagliptyna".
- Saxagliptin label "Saptagliptina".
- Saxagliptin label "Saxagliptin".
- Saxagliptin label "Saxagliptina".
- Saxagliptin label "Saxagliptine".
- Saxagliptin sameAs Saptagliptina.
- Saxagliptin sameAs Saxagliptine.
- Saxagliptin sameAs Saksagliptyna.
- Saxagliptin sameAs Saxagliptina.
- Saxagliptin sameAs m.01xm8qw.
- Saxagliptin sameAs Q3121121.
- Saxagliptin sameAs Q3121121.
- Saxagliptin sameAs Saxagliptin.
- Saxagliptin wasDerivedFrom Saxagliptin?oldid=605387173.
- Saxagliptin depiction Saxagliptin.svg.
- Saxagliptin homepage www.onglyza.com.
- Saxagliptin isPrimaryTopicOf Saxagliptin.
